Literature DB >> 12370095

Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats.

Zi-Pu Li1, Qian Cao.   

Abstract

AIM: To explore the effects of astragaloside IV (XGA) on myocardial calcium transport and cardiac function in ischemic rats.
METHODS: Eighty-four Wistar rats were divided into three groups: control group (n=12); ischemic group (n=12) was given isoprenaline injection sc at a dose of 30 mg/kg; and XGA group (n=60) was given XGA after isoprenaline administration. The changes of the parameters of hemodynamics, cardiac function, and intra- and extracellular calcium concentration of the myocardial cells were determined. The dose- and time-effect relationship of XGA on myocardial calcium transport and cardiac function were observed.
RESULTS: After XGA administration, there was significant improvement in cardiac function and hemodynamics in ischemic rats. The cardiac output, heart rate, stroke volume, mean aortic pressure, systolic aortic pressure, the stroke work of left ventricule, the right and left ventricle systolic pressure, and +dp/dt of the right ventricle of ischemic rats gradually recovered to the level of the control group with increasing the dose of XGA and prolongation of the action of XGA. The ionized calcium of the myocardium and the total amount of calcium of the myocardial tissue decreased markedly compared to those in ischemic group, and the activity of calcium pump of erythrocyte membrane increased significantly in comparison to that of ischemic group, but their changes had no trend of increase with increasing dose of the XGA. However, there was a gradual decrease of the ionized calcium of the myocardium with the prolongation of acting time of XGA.
CONCLUSION: XGA improves the cardiac function in ischemic rats, and the reduction of excessive accumulation of intracellular calcium within myocardial cells plays an important role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370095

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  19 in total

Review 1.  Research progress on mechanism of action of Radix Astragalus in the treatment of heart failure.

Authors:  Qing-You Yang; Ke-Ji Chen; Shu Lu; Hui-Ru Sun
Journal:  Chin J Integr Med       Date:  2012-04-02       Impact factor: 1.978

2.  Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.

Authors:  C R Huang; G J Wang; X L Wu; H Li; H T Xie; H Lv; J G Sun
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

3.  Astragaloside IV attenuates myocardial ischemia/reperfusion injury in rats via inhibition of calcium-sensing receptor-mediated apoptotic signaling pathways.

Authors:  Bo Yin; Xu-Wei Hou; Mei-Li Lu
Journal:  Acta Pharmacol Sin       Date:  2018-07-20       Impact factor: 6.150

4.  Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling.

Authors:  Tong Chen; Ruoning Wang; Wenjiao Jiang; Huimin Wang; Ang Xu; Guo Lu; Yi Ren; Yangmei Xu; Yangyang Song; Shoulei Yong; Hui Ji; Zhanqiang Ma
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

5.  Protective Effects of Danlou Tablet () against Murine Myocardial Ischemia and Reperfusion Injury In Vivo.

Authors:  Jian-Yong Qi; Lei Wang; Dong-Sheng Gu; Li-Heng Guo; Wei Zhu; Min-Zhou Zhang
Journal:  Chin J Integr Med       Date:  2016-03-21       Impact factor: 1.978

6.  Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice.

Authors:  Jianyong Qi; Juan Yu; Lei Wang; Liheng Guo; Shiyu Ma; Donghui Huang; Miao Zhou; Jiashin Wu; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

7.  Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels.

Authors:  Yixin He; Min Du; Yan Gao; Hongshuai Liu; Hongwei Wang; Xiaojun Wu; Zhengtao Wang
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury.

Authors:  Jingwen Si; Ning Wang; Huan Wang; Juan Xie; Jian Yang; Hui Yi; Zixuan Shi; Jing Ma; Wen Wang; Lifang Yang; Shiqiang Yu; Junchang Li
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

9.  Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats.

Authors:  Ruiqin Huang; Min Li
Journal:  Saudi Pharm J       Date:  2016-05-04       Impact factor: 4.330

10.  HPLC-DAD-ELSD Combined Pharmacodynamics and Serum Medicinal Chemistry for Quality Assessment of Huangqi Granule.

Authors:  Huaguo Chen; Xin Zhou; Yang Zhao; Xiao-Jian Gong; Yan He; Feng-Wei Ma; Mei Zhou; Chao Zhao; Yi Niu; Jie Deng
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.